Zhang Dong, Li Hongliang, Gan Weimin
Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Mol Clin Oncol. 2016 Apr;4(4):597-598. doi: 10.3892/mco.2016.775. Epub 2016 Feb 10.
Prostate cancer is one of the most common male malignancies, although it rarely metastasizes to the ureter. The present case study reported a 63-year-old man who presented with asymptomatic right hydronephrosis, detected by ultrasound. Computed tomography urography demonstrated right hydronephrosis, secondary to thickening of the distal ureter. The patient's serum concentration of prostate specific antigen was 111.400 ng/ml, and a prostate needle biopsy revealed prostate adenocarcinoma, with a Gleason score of 4+5=9. Renal scintigraphy revealed poor excretion of the right kidney. A nephroureterectomy was subsequently performed, and a histological examination revealed a metastatic prostate adenocarcinoma of the ureter. Combined androgen blockage therapy with bicalutamide (50 mg, once daily) and goserelin (3.6 mg, once a month) was administered to the patient. At 3 months of follow-up, the patient's PSA levels had decreased to 0.322 ng/ml; at 6 months of follow-up, the PSA levels had further decreased to 0.136 ng/ml.
前列腺癌是最常见的男性恶性肿瘤之一,尽管它很少转移至输尿管。本病例报告了一名63岁男性,经超声检查发现有无症状的右侧肾积水。计算机断层扫描尿路造影显示右侧肾积水,继发于远端输尿管增厚。患者血清前列腺特异性抗原浓度为111.400 ng/ml,前列腺穿刺活检显示为前列腺腺癌,Gleason评分为4+5=9。肾闪烁显像显示右肾排泄功能差。随后进行了肾输尿管切除术,组织学检查显示为输尿管转移性前列腺腺癌。对患者采用比卡鲁胺(50 mg,每日一次)和戈舍瑞林(3.6 mg,每月一次)联合雄激素阻断治疗。随访3个月时,患者的PSA水平降至0.322 ng/ml;随访6个月时,PSA水平进一步降至0.136 ng/ml。